A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen

Background: The Influenza A virus (IAV), a pathogen affecting the respiratory system, represents a major risk to public health worldwide. Immunization remains the foremost strategy to control the transmission of IAV. The virus has two primary antigens: hemagglutinin (HA) and neuraminidase (NA). Our...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengyuan Liu, Yixuan Liu, Shaohui Song, Qiurong Qiao, Jing Liu, Yun Xie, Jian Zhou, Guoyang Liao
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/1/91
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587378466750464
author Mengyuan Liu
Yixuan Liu
Shaohui Song
Qiurong Qiao
Jing Liu
Yun Xie
Jian Zhou
Guoyang Liao
author_facet Mengyuan Liu
Yixuan Liu
Shaohui Song
Qiurong Qiao
Jing Liu
Yun Xie
Jian Zhou
Guoyang Liao
author_sort Mengyuan Liu
collection DOAJ
description Background: The Influenza A virus (IAV), a pathogen affecting the respiratory system, represents a major risk to public health worldwide. Immunization remains the foremost strategy to control the transmission of IAV. The virus has two primary antigens: hemagglutinin (HA) and neuraminidase (NA). Our previous studies have demonstrated that an IAV NA mRNA vaccine can induce Th1-type immune responses in mice. This research examined the immune responses elicited by an mRNA vaccine targeting both HA and NA antigens in murine models. Methods: In this study, we used two dual-antigen immunization strategies: single-site immunization with an IAV HA+NA mRNA vaccine and multi-site immunization with an IAV HA mRNA vaccine and IAV NA mRNA vaccine. Hemagglutination-inhibiting antibody titer and neutralizing antibody titer in the sera of immunized mice were evaluated, and a viral challenge experiment was conducted. Additionally, the immune responses elicited by the two immunization strategies were characterized using flow cytometry and ELISA. Comparative analyses were performed with mice immunized individually with the IAV HA mRNA vaccine, IAV NA mRNA vaccine, and inactivated vaccine. Results: The results showed that by using a multi-site immunization strategy, mice were able to generate higher levels of hemagglutination-inhibiting and neutralizing antibodies, and were protected in a viral challenge experiment. Moreover, the multi-site regimen also promoted the generation of cytotoxic T cells and maintained a balanced Th1/Th2 immune response. Conclusions: Using mRNA vaccine based on a HA and NA antigen with multi-site immunization strategy can induce higher levels of hemagglutination-inhibiting and neutralizing antibodies, and multi-type immune responses in mice, providing new theoretical and experimental support for advancing upcoming influenza vaccines.
format Article
id doaj-art-a9f1790e9c9a455c833f6b5a1454b88d
institution Kabale University
issn 2076-393X
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj-art-a9f1790e9c9a455c833f6b5a1454b88d2025-01-24T13:51:54ZengMDPI AGVaccines2076-393X2025-01-011319110.3390/vaccines13010091A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase AntigenMengyuan Liu0Yixuan Liu1Shaohui Song2Qiurong Qiao3Jing Liu4Yun Xie5Jian Zhou6Guoyang Liao7Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaKunming Medical University, Kunming 650500, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaBackground: The Influenza A virus (IAV), a pathogen affecting the respiratory system, represents a major risk to public health worldwide. Immunization remains the foremost strategy to control the transmission of IAV. The virus has two primary antigens: hemagglutinin (HA) and neuraminidase (NA). Our previous studies have demonstrated that an IAV NA mRNA vaccine can induce Th1-type immune responses in mice. This research examined the immune responses elicited by an mRNA vaccine targeting both HA and NA antigens in murine models. Methods: In this study, we used two dual-antigen immunization strategies: single-site immunization with an IAV HA+NA mRNA vaccine and multi-site immunization with an IAV HA mRNA vaccine and IAV NA mRNA vaccine. Hemagglutination-inhibiting antibody titer and neutralizing antibody titer in the sera of immunized mice were evaluated, and a viral challenge experiment was conducted. Additionally, the immune responses elicited by the two immunization strategies were characterized using flow cytometry and ELISA. Comparative analyses were performed with mice immunized individually with the IAV HA mRNA vaccine, IAV NA mRNA vaccine, and inactivated vaccine. Results: The results showed that by using a multi-site immunization strategy, mice were able to generate higher levels of hemagglutination-inhibiting and neutralizing antibodies, and were protected in a viral challenge experiment. Moreover, the multi-site regimen also promoted the generation of cytotoxic T cells and maintained a balanced Th1/Th2 immune response. Conclusions: Using mRNA vaccine based on a HA and NA antigen with multi-site immunization strategy can induce higher levels of hemagglutination-inhibiting and neutralizing antibodies, and multi-type immune responses in mice, providing new theoretical and experimental support for advancing upcoming influenza vaccines.https://www.mdpi.com/2076-393X/13/1/91influenza A virusmRNA vaccinehemagglutininneuraminidaseTh1Th2
spellingShingle Mengyuan Liu
Yixuan Liu
Shaohui Song
Qiurong Qiao
Jing Liu
Yun Xie
Jian Zhou
Guoyang Liao
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
Vaccines
influenza A virus
mRNA vaccine
hemagglutinin
neuraminidase
Th1
Th2
title A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
title_full A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
title_fullStr A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
title_full_unstemmed A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
title_short A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
title_sort study on the induction of multi type immune responses in mice via an mrna vaccine based on hemagglutinin and neuraminidase antigen
topic influenza A virus
mRNA vaccine
hemagglutinin
neuraminidase
Th1
Th2
url https://www.mdpi.com/2076-393X/13/1/91
work_keys_str_mv AT mengyuanliu astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT yixuanliu astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT shaohuisong astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT qiurongqiao astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT jingliu astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT yunxie astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT jianzhou astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT guoyangliao astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT mengyuanliu studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT yixuanliu studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT shaohuisong studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT qiurongqiao studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT jingliu studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT yunxie studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT jianzhou studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen
AT guoyangliao studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen